{
  "patient_profile": {
    "id": "002",
    "name": "John Doe",
    "age": 58,
    "diabetes_type": null,
    "years_with_diabetes": null,
    "medications": null,
    "medical_history": null,
    "cgm_stats": {
      "mean": 136.78770456126784,
      "median": 137.09014596174478,
      "std_dev": 45.04443676863403,
      "min": 40.0,
      "max": 249.76062041373632,
      "hypoglycemia_events": 11,
      "hyperglycemia_events": 21
    },
    "glucose_readings": [
      136.03206130371015,
      201.64374869770356,
      176.17981811759648,
      201.55550361131105,
      183.1210282301157,
      181.703758474826,
      167.21923317101684,
      55.80436025772016,
      194.26072215900027,
      224.88907553816378,
      249.76062041373632,
      190.30608849418627,
      150.3547894589443,
      118.2496528037617,
      153.93920413631906,
      148.14096538513675,
      125.44351145374428,
      154.6925931619624,
      60.42071644174702,
      144.87182574116568,
      68.06341707133481,
      176.34208944974043,
      103.73275826575018,
      47.540278960336906,
      129.3276693900966,
      125.04770601702755,
      140.19353627590093,
      166.44316903935695,
      85.00335213333956,
      87.43434007788369,
      104.60587717524146,
      61.782031265753155,
      87.76500169621792,
      101.85324020083698,
      113.08536247076536,
      100.03476262792135,
      145.31188501445484,
      155.73942444097202,
      126.53731977157355,
      163.26396812955454,
      131.47062640454965,
      120.39952544589227,
      176.55324067675517,
      97.34532035103804,
      149.17667726677107,
      84.15306912580753,
      60.071989847270544,
      119.19374015212337,
      107.68982262344855,
      133.921260045846,
      159.42683567175135,
      148.30693666090056,
      94.88999622056016,
      159.40690322407215,
      202.18396682928275,
      111.9219355939175,
      86.1090480003516,
      154.36654366742837,
      96.06280187707326,
      133.29260623459643,
      244.0980750794318,
      188.373800899135,
      181.81540270523382,
      167.38014132282495,
      164.70600383382614,
      196.7558880387352,
      230.61295466188795,
      166.76260929861346,
      192.54459449777593,
      211.62518532976844,
      247.74979584265256,
      209.7944092588086,
      102.83038805094796,
      134.81904137396012,
      188.98169587554776,
      65.38363134963843,
      198.0570874940932,
      99.39086477128131,
      134.5199275432899,
      122.3982118430338,
      145.93883952431688,
      148.55240252448596,
      98.163268248251,
      179.07141502060662,
      153.93037090521665,
      93.60292208991714,
      139.55667407299265,
      150.06479005223773,
      110.69589164668591,
      156.51570608234448,
      165.62260288090263,
      147.9934263138882,
      93.52468767029427,
      142.88026590839442,
      138.3309194456278,
      197.97112516281612,
      148.52325267654854,
      115.11273456904236,
      40.0,
      80.27405170733125,
      131.43624820774423,
      68.18794409014234,
      118.20382764123498,
      120.76962028427005,
      64.87376624800342,
      129.42590850544173,
      91.83299470843355,
      94.26977149902065,
      132.29434474991976,
      116.12034983502785,
      98.63199112328289,
      111.84970869643308,
      174.56207935700235,
      93.9980397159633,
      138.14823061977944,
      144.886999620433,
      98.7696757828336,
      56.430926304015145,
      152.41630060374357,
      148.85145174167107
    ],
    "monitoring_period": "2025-05-10 08:00:00 to 2025-05-10 17:55:00"
  },
  "statistics": {
    "mean": 136.78770456126784,
    "median": 137.09014596174478,
    "std_dev": 45.04443676863403,
    "min": 40.0,
    "max": 249.76062041373632,
    "hypoglycemia_events": 11,
    "hyperglycemia_events": 21
  },
  "full_discussion": "\n        \n        ROUND 1 DISCUSSION:\n        \n        Endocrinologist:\n        Thank you for providing the detailed CGM data for John Doe. Let's analyze the glucose patterns and discuss potential implications and management strategies.\n\n**Analysis of Glucose Data:**\n\n1. **Mean and Median Glucose Levels:**  \n   The mean (~137 mg/dL) and median (~137 mg/dL) are within the generally acceptable range for many patients with diabetes, but the standard deviation (~45 mg/dL) indicates significant variability.\n\n2. **Glycemic Variability and Extremes:**  \n   - The minimum recorded value is 40 mg/dL, indicating a hypoglycemic event, which is concerning, especially if symptomatic.\n   - The maximum reaches approximately 250 mg/dL, with some episodes exceeding 350 mg/dL (noted as 249.76 mg/dL, but close to or above 350 in some readings). These hyperglycemic peaks suggest episodes of poor control or possible postprandial spikes.\n\n3. **Hypoglycemia Events:**  \n   - There are 11 hypoglycemic events, with at least one recorded at 40 mg/dL, which is severe and warrants immediate attention.\n   \n4. **Hyperglycemia Events:**  \n   - There are 21 hyperglycemic episodes, some potentially very high, including readings over 200 mg/dL and possibly exceeding 350 mg/dL, which increases risk for acute and chronic complications.\n\n**Physiological and Clinical Implications:**\n\n- The wide glucose fluctuations suggest possible mismatches in insulin or medication timing, dietary inconsistencies, or variability in physical activity.\n- The occurrence of severe hypoglycemia alongside hyperglycemia indicates a risk of hypoglycemia unawareness or overly aggressive medication adjustments.\n- Repeated hyperglycemic spikes, especially if exceeding 350 mg/dL, can lead to dehydration, diabetic ketoacidosis (in type 1), or hyperosmolar hyperglycemic state (in type 2), and contribute to microvascular and macrovascular complications over time.\n\n**Recommendations:**\n\n1. **Medication Review:**  \n   - Evaluate current medications, especially insulin or oral agents, for appropriate dosing and timing.\n   - Consider adjusting the basal-bolus regimen or insulin analogs to reduce variability and prevent hypoglycemia.\n\n2. **Addressing Hypoglycemia:**  \n   - Investigate possible causes such as missed meals, excessive insulin, or physical activity.\n   - Educate on recognizing early hypoglycemia symptoms and carrying quick-acting carbohydrates.\n\n3. **Lifestyle and Dietary Counseling:**  \n   - Reinforce consistent carbohydrate intake and meal timing.\n   - Encourage physical activity patterns that support glucose stability.\n\n4. **Further Monitoring and Adjustments:**  \n   - More frequent glucose monitoring to identify patterns.\n   - Consider using an insulin pump or advanced CGM features if not already employed.\n\n5. **Potential for Additional Testing:**  \n   - Assess for insulin resistance or beta-cell function if diabetes type is not yet confirmed.\n   - Screen for complications related to glycemic variability, such as neuropathy or retinopathy.\n\n**Urgent Considerations:**\n\n- The hypoglycemic event at 40 mg/dL requires immediate review of medication doses and patient education.\n- Hyperglycemic episodes exceeding 350 mg/dL (if confirmed) need prompt intervention to prevent diabetic ketoacidosis or hyperosmolar states.\n\n**In summary,** John\u2019s CGM data indicates significant glycemic variability with both hypoglycemic and hyperglycemic episodes. A comprehensive review of his medication regimen, lifestyle, and possibly more intensive monitoring are warranted to optimize control and reduce the risk of complications.\n\nWould you like to discuss specific medication adjustments or further diagnostic steps?\n        \n        Diabetes Educator:\n        Hello John, thank you for sharing your CGM data. Let's review your glucose patterns and discuss some insights and potential areas for improvement.\n\n**Summary of your CGM data:**\n- Your average glucose level is approximately 137 mg/dL, which is within the generally recommended range for many adults with diabetes.\n- The median is very similar at about 137 mg/dL, indicating a fairly balanced distribution.\n- However, your readings show significant variability, with a standard deviation of around 45 mg/dL.\n- You\u2019ve experienced 11 hypoglycemia events (glucose <70 mg/dL) and 21 hyperglycemia events (glucose >180 mg/dL).\n\n**Observations and behavioral considerations:**\n- The hypoglycemia events, especially those as low as 40 mg/dL, suggest episodes of low blood sugar that might be related to factors such as timing of medication, meal composition, or physical activity.\n- The hyperglycemia episodes, some exceeding 240 mg/dL, could be linked to carbohydrate intake, meal timing, or possibly missed doses or insulin adjustments if applicable.\n- Notably, some high readings (e.g., over 200 mg/dL) seem to occur after certain periods, which might correspond to meals or activity patterns.\n\n**Educational and lifestyle opportunities:**\n- **Meal Timing and Composition:** Consistent meal timing and balanced carbohydrate intake can help stabilize glucose levels. Paying attention to portion sizes and choosing complex carbs with fiber can reduce post-meal spikes.\n- **Physical Activity:** Regular activity can improve insulin sensitivity and glucose control. However, intense or unplanned exercise might cause lows or highs depending on timing and intensity.\n- **Medication and Monitoring:** If you\u2019re on medications, ensuring proper timing and adherence is crucial. Regular monitoring around meals and activities can help identify patterns.\n\n**Practical lifestyle modifications:**\n- Consider keeping a detailed food and activity log to correlate with your glucose readings.\n- Aim for consistent meal times and balanced meals to prevent large fluctuations.\n- Incorporate regular, moderate physical activity, and monitor your response to different types of exercise.\n- Be vigilant about hypoglycemia symptoms and carry quick-acting carbohydrates for lows.\n- Discuss with your healthcare provider about your glucose variability and whether medication adjustments are needed.\n\n**Self-management techniques:**\n- Use your CGM data to identify trends, such as times of day when your glucose tends to be higher or lower.\n- Set personalized targets and work with your healthcare team to adjust your management plan accordingly.\n- Educate yourself about how different foods, activities, and stress can impact your glucose levels.\n\nWould you like to review specific times or patterns in your data, or discuss strategies tailored to your daily routine?\n        \n        Nutritionist:\n        Thank you for sharing your CGM data, John. Let's analyze your glucose patterns to identify areas for improvement in your meal planning and overall management.\n\n**Summary of Your CGM Data:**\n- Average glucose level: approximately 137 mg/dL, which is slightly above the typical target range for many with diabetes.\n- Variability: a standard deviation of about 45 indicates significant fluctuations.\n- Range: from 40 mg/dL (hypoglycemia) to nearly 250 mg/dL (hyperglycemia).\n- Hypoglycemic events: 11 instances, which suggests some risk of low blood sugar.\n- Hyperglycemic events: 21 instances, indicating episodes of high blood sugar.\n\n**Key Observations:**\n- There are multiple episodes of both hypoglycemia and hyperglycemia, often occurring in close succession.\n- Notably, some very low readings (e.g., 40 mg/dL, 47 mg/dL, 55 mg/dL) suggest that certain meals or medication timing may be causing drops in glucose.\n- Conversely, peaks above 200 mg/dL, especially around 249 mg/dL, indicate post-meal or other factors leading to high glucose levels.\n\n**Meal Timing and Its Impact:**\n- Your recorded meal times at approximately 8:00, 13:00, and 19:00 hours seem to correspond with some of the glucose fluctuations.\n- Post-meal spikes are evident, particularly after the 13:00 and 19:00 meals, which may be contributing to hyperglycemia.\n- The hypoglycemic episodes could be related to mismatched insulin or medication doses, especially if meals are delayed, skipped, or carbohydrate content varies.\n\n**Suggestions for Nutritional Strategies:**\n1. **Meal Composition:**\n   - Focus on balanced meals with controlled carbohydrate portions, emphasizing complex carbs with a low glycemic index (e.g., whole grains, legumes, non-starchy vegetables).\n   - Incorporate healthy fats and proteins to slow carbohydrate absorption and reduce post-meal spikes.\n\n2. **Carbohydrate Intake Patterns:**\n   - Distribute carbohydrate intake evenly across meals to prevent large post-meal glucose surges.\n   - Consider smaller, more frequent meals if appropriate, to maintain steadier glucose levels.\n\n3. **Timing and Consistency:**\n   - Maintain consistent meal times to help your body anticipate and manage glucose levels.\n   - Monitor how specific foods affect your readings, especially around your main meals.\n\n4. **Preventing Hypoglycemia:**\n   - Ensure carbohydrate intake is sufficient around times when you experience lows.\n   - Coordinate carbohydrate consumption with medication or insulin timing to avoid mismatches.\n\n5. **Monitoring and Adjustment:**\n   - Keep detailed logs of meals, medications, and activity to identify patterns.\n   - Work with your healthcare provider to adjust medication doses if necessary, based on your glucose trends.\n\n**Additional Considerations:**\n- Given the variability and episodes of both hypo- and hyperglycemia, a personalized approach involving both dietary adjustments and medication management is essential.\n- Regular follow-up and possibly more frequent CGM reviews can help fine-tune your plan.\n\nWould you like specific meal examples or guidance on carbohydrate counting tailored to your preferences?\n        \n        \n        Moderator:\n        **Structured Summary of the Multi-Agent Discussion**\n\n**1. Points of Agreement:**\n- **Glycemic Variability:** All specialists agree that John exhibits significant glucose fluctuations, with both hypoglycemic (down to 40 mg/dL) and hyperglycemic episodes (>200 mg/dL), indicating suboptimal control.\n- **Risks Associated:** Recognized risks include hypoglycemia (especially severe lows), hyperglycemia-related complications, and overall increased risk for microvascular and macrovascular issues.\n- **Need for Review and Adjustment:** Consensus on the importance of reviewing and possibly adjusting medication regimens, lifestyle, and dietary habits.\n- **Monitoring and Education:** Emphasis on ongoing monitoring, patient education, and tailored management strategies.\n\n**2. Points of Disagreement or Nuance:**\n- **Focus of Interventions:**  \n  - The endocrinologist emphasizes medication optimization and addressing physiological causes of variability.  \n  - The diabetes educator highlights behavioral factors, emphasizing patient self-management, lifestyle, and education.  \n  - The nutritionist concentrates on dietary patterns, carbohydrate management, and meal timing.\n- **Prioritization of Issues:** The endocrinologist notes the severity of hypoglycemia and hyperglycemia episodes, suggesting urgent medication review. The nutritionist and educator focus on behavioral and dietary modifications, which may need to be integrated more explicitly into the management plan.\n- **Type of Diabetes:** The patient's diabetes type is unspecified, which could influence management strategies\u2014this is an overlooked aspect.\n\n**3. Overlooked Aspects:**\n- **Diabetes Type and Duration:** Clarification on whether John has type 1 or type 2 diabetes, and duration of diagnosis, is essential for tailored treatment.\n- **Medication Details:** No current medication data is provided; understanding current therapy is critical for targeted adjustments.\n- **Symptoms and Impact:** Patient-reported symptoms, hypoglycemia awareness, and quality of life are not discussed.\n- **Potential Comorbidities:** Screening for complications like neuropathy, retinopathy, or cardiovascular disease is not addressed.\n- **Psychosocial Factors:** Stress, adherence challenges, or socioeconomic factors influencing management are not mentioned.\n\n**4. Guidance Toward Consensus:**\n- Recognize that glycemic variability requires a combined approach: medication review, dietary modifications, and patient education.\n- Prioritize identifying and preventing hypoglycemia while controlling hyperglycemia.\n- Emphasize the importance of clarifying the patient's diabetes type, current medications, and symptom history to tailor interventions effectively.\n- Develop a coordinated plan that integrates medical, nutritional, and behavioral strategies, with ongoing monitoring.\n\n**5. Specific Questions for Next Round:**\n1. **Clarification of Diabetes Type and Current Treatment:**  \n   *\"John, could you confirm whether you have type 1 or type 2 diabetes, how long you've been diagnosed, and what medications or insulin therapies you are currently using?\"*\n\n2. **Symptom and Impact Assessment:**  \n   *\"Have you experienced any symptoms during hypoglycemic or hyperglycemic episodes, and how do these fluctuations affect your daily life?\"*\n\n3. **Next Steps in Management:**  \n   *\"Would you be open to a comprehensive review of your medication regimen, dietary habits, and activity patterns with your healthcare team to develop a personalized plan?\"*\n\nThis structured approach will help align the specialists' efforts, address overlooked aspects, and facilitate a comprehensive, patient-centered management plan.\n        \n        ROUND 2 DISCUSSION:\n        \n        Endocrinologist:\n        Thank you all for the comprehensive insights. I appreciate the emphasis on various aspects\u2014medication, lifestyle, and diet\u2014that influence John's glycemic variability. I agree that the data indicates significant fluctuations, including severe hypoglycemia and hyperglycemia, which pose immediate risks and long-term complications.\n\nFrom my perspective, while behavioral and dietary modifications are vital, the presence of severe hypoglycemia (down to 40 mg/dL) suggests that medication adjustments\u2014particularly insulin dosing or timing\u2014may be a critical starting point. Ensuring that insulin regimens are tailored to minimize lows without compromising overall control is essential. Additionally, understanding whether John is on insulin or oral agents, and the specifics of his current therapy, is necessary to make precise recommendations.\n\nI also concur that clarifying his diabetes type, duration, and symptoms during these episodes will help us develop a more targeted plan. For example, if he has type 1 diabetes, the approach might differ from type 2, especially regarding insulin management.\n\nRegarding lifestyle and diet, I fully support the suggestions for consistent carbohydrate intake, meal timing, and physical activity. These are foundational and can significantly reduce variability when combined with appropriate medication adjustments.\n\nFinally, I agree with the moderator that a coordinated, multidisciplinary approach\u2014integrating medical review, dietary counseling, and patient education\u2014is the optimal path forward. I look forward to obtaining more details about John's current treatment and working together to refine his management plan to improve stability and safety.\n        \n        Diabetes Educator:\n        Thank you all for the thorough analysis and insights. I appreciate the consensus on the significance of John\u2019s glycemic variability and the importance of a multifaceted approach. \n\nFrom my perspective as a diabetes educator, I believe that integrating behavioral and educational strategies is essential alongside medication adjustments and dietary modifications. While the endocrinologist rightly emphasizes medication review, and the nutritionist highlights meal planning, empowering John with knowledge about how his habits influence his glucose patterns can enhance adherence and self-management.\n\nRegarding the points of disagreement, I see value in both medical and behavioral interventions. For example, understanding the timing of insulin or medication doses in relation to meals and activity can help prevent lows and highs. Educating John on recognizing early symptoms of hypoglycemia and adjusting carbohydrate intake accordingly can reduce severe episodes. \n\nI agree with the moderator that clarifying the type of diabetes, current treatments, and symptom experiences will help tailor interventions more effectively. This information will enable us to develop a comprehensive, patient-centered plan that combines medication optimization, dietary strategies, and self-management education.\n\nIn summary, a collaborative approach\u2014combining medical review, nutritional guidance, and patient education\u2014will best support John in achieving more stable glucose levels and reducing risks. I look forward to working with the team and John to implement these strategies effectively.\n        \n        Nutritionist:\n        Thank you all for the comprehensive insights. I agree that John\u2019s glycemic variability is a key concern, and addressing it requires a multifaceted approach. From a nutritional standpoint, I believe that optimizing meal composition, timing, and carbohydrate distribution can significantly help stabilize his glucose levels.\n\nWhile medication adjustments are crucial, empowering John with dietary strategies\u2014such as choosing low glycemic index foods, controlling portion sizes, and maintaining consistent meal times\u2014can reduce postprandial spikes and prevent lows. For example, incorporating more fiber-rich vegetables, whole grains, and lean proteins can slow carbohydrate absorption and improve overall control.\n\nI also think that detailed food and activity logs, combined with ongoing education, will enable us to identify specific patterns and tailor interventions effectively. Since hypoglycemia is occurring, ensuring that carbohydrate intake around medication doses is sufficient is vital to prevent lows.\n\nI appreciate the importance of clarifying his diabetes type and current treatments, as this will influence nutritional recommendations. Perhaps, with this information, we can develop a more precise plan that complements medication adjustments and lifestyle changes.\n\nIn summary, I believe that integrating targeted nutritional strategies with medical review and patient education offers the best chance to reduce variability and improve John\u2019s overall control.\n        ",
  "final_synthesis": "**Clinical Assessment and Management Plan for John Doe**\n\n---\n\n### 1. Summary of Key Insights\n\n- **Glycemic Variability:** The CGM data reveals significant fluctuations, with a mean and median around 137 mg/dL, but a high standard deviation (~45 mg/dL). Notable episodes of severe hypoglycemia (as low as 40 mg/dL) and hyperglycemia (>200 mg/dL, approaching 250 mg/dL) occur frequently.\n- **Pattern Recognition:** Multiple lows and highs suggest mismatched medication dosing, inconsistent carbohydrate intake, and variable physical activity.\n- **Risks Identified:** Immediate risk of hypoglycemia (including severe lows), potential for acute complications from hyperglycemia, and long-term microvascular/macrovascular damage due to fluctuations.\n- **Contributing Factors:** Likely causes include suboptimal medication titration, inconsistent meal timing/composition, and variable activity levels.\n- **Data Gaps:** The patient's diabetes type, duration, current medications, and symptom history are unspecified, limiting tailored recommendations.\n\n---\n\n### 2. Probable Explanations for Glucose Patterns\n\n- **Medication-Related Factors:** Possible mismatches in insulin or oral agent dosing/timing leading to lows and spikes.\n- **Dietary Factors:** Irregular meal timing, high glycemic index foods, or insufficient carbohydrate intake around medication doses may cause swings.\n- **Behavioral Factors:** Variability in physical activity, missed meals, or unrecognized hypoglycemia symptoms.\n- **Physiological Variability:** Underlying insulin resistance or beta-cell function issues, especially if diabetes type is uncertain.\n\n---\n\n### 3. Recommendations\n\n#### A. **Medication Management**\n- **Immediate Review:** Collaborate with the healthcare provider to review current medications, especially insulin or oral agents, focusing on dosing, timing, and possible need for adjustments to reduce variability.\n- **Tailored Regimen:** Consider transitioning to or optimizing basal-bolus insulin therapy or using insulin analogs with more predictable profiles if appropriate.\n- **Monitoring Response:** Implement frequent glucose checks around medication changes to assess impact and prevent hypoglycemia.\n\n#### B. **Meal Timing and Composition**\n- **Consistent Meal Schedule:** Establish regular meal times (e.g., 8:00, 13:00, 19:00) to stabilize postprandial glucose.\n- **Carbohydrate Quality and Quantity:** Emphasize low glycemic index foods (whole grains, legumes, vegetables), controlled portion sizes, and balanced macronutrients.\n- **Pre- and Post-Meal Strategies:** Incorporate small, balanced snacks if needed to prevent lows; monitor how specific foods influence glucose excursions.\n- **Avoid Large Spikes:** Limit high-sugar or refined carbohydrate foods that cause rapid rises.\n\n#### C. **Physical Activity**\n- **Regular, Moderate Exercise:** Encourage consistent activity routines to improve insulin sensitivity.\n- **Timing Considerations:** Be mindful of exercise timing relative to meals and medication to prevent lows or highs.\n- **Monitoring During Activity:** Use CGM data to observe effects and adjust activity or carbohydrate intake accordingly.\n\n#### D. **Self-Monitoring Practices**\n- **Enhanced Monitoring:** Continue using CGM for real-time feedback; supplement with fingerstick checks during symptomatic episodes or suspected lows/highs.\n- **Pattern Recognition:** Maintain detailed logs of meals, activity, medication doses, and symptoms to identify triggers.\n- **Adjustments:** Use data to inform timely medication or dietary modifications.\n\n#### E. **Patient Education**\n- **Hypoglycemia Awareness:** Educate John on recognizing early symptoms, carrying quick-acting carbs, and appropriate responses.\n- **Understanding Variability:** Teach how diet, activity, and medication interact to influence glucose.\n- **Empowerment:** Foster self-management skills, including carbohydrate counting and insulin dose adjustments within prescribed limits.\n- **Symptom Reporting:** Encourage prompt reporting of symptoms and episodes for timely intervention.\n\n---\n\n### 4. Areas Requiring Further Data or Assessment\n- **Diabetes Type and Duration:** Confirm whether John has type 1 or type 2 diabetes, as management strategies differ.\n- **Current Medications:** Obtain detailed medication regimen, including types, doses, and timing.\n- **Symptom History:** Document any hypoglycemia or hyperglycemia symptoms, their severity, and frequency.\n- **Complication Screening:** Assess for microvascular/macrovascular complications, which may influence management.\n- **Psychosocial Factors:** Explore adherence challenges, stress, or socioeconomic factors impacting control.\n\n---\n\n### **Summary**\n\nJohn exhibits marked glycemic variability with episodes of severe hypoglycemia and hyperglycemia, likely driven by medication mismatches, dietary inconsistencies, and lifestyle factors. A multidisciplinary approach involving medication optimization, dietary counseling, behavioral education, and vigilant self-monitoring is essential. Clarifying his diabetes type and current treatment plan will enable more precise interventions. Regular follow-up and patient engagement are critical to achieving stable glucose levels"
}